US Fraunhofer Center Develops Method for Mass Manufacture of Low-Cost Continuous Flow PCR Devices

Mar 30, 2016

|

Premium

NEW YORK (GenomeWeb) – For about two decades, widespread use of point-of-care molecular testing technologies has seemed to be just beyond the horizon, but microfluidics' manufacturing costs may have limited their uptake.

Researchers at the Fraunhofer Center for Manufacturing Innovation in Brookline, Massachusetts have now developed a low-cost method to construct continuous-flow real-time PCR devices, which could potentially push POC molecular testing further into the mainstream.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

Keep Them or Not?

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

Dunno Whose It Is

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

Knowing Risk From a Young Age

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

Science Translational Medicine Paper Finds Drug Combo Boosts KRAS Inhibitor Efficacy in Lung Cancer

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.

Featured White Papers

Sample Normalization with RNAGEM

RNAGEM - mRNA Profiles as Close to Biological Reality as Possible

Cell-Based Therapies – Be on the Safe Side

Poster: Next Generation Cellular Therapeutic Technologies — Rapid Detection of Bacterial Contamination

Oct

23

Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.

Oct

24

Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Menu